Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Bayer AG logo
BAYN.DE
Bayer AG
13:12:10
37.29 €
0.0000 (%0.00)
Previous Close: 37.15
Day Low₺36.84
Day High₺37.55
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

BAYN.DE: Bayer AG Financials

Bayer AG Income Statement

Total revenue
Net income
Gross margin TTM
59.21%
Operating margin TTM
15.26%
Net profit margin TTM
-7.94%
Return on investment TTM
-13.95%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue45,575,000,00046,606,000,00047,637,000,00050,739,000,000
Operating income6,954,000,0004,479,000,0008,409,000,0008,239,000,000
Net income-3,620,000,000-2,552,000,000-2,941,000,0004,150,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue45,575,000,00046,606,000,00047,637,000,00050,739,000,000
Cost of revenue18,592,000,00021,270,000,00019,749,000,00019,871,000,000
Gross profit26,983,000,00025,336,000,00027,888,000,00030,868,000,000
Research and development expenses5,769,000,0006,209,000,0005,371,000,0006,572,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses14,270,000,00014,678,000,00014,332,000,00016,222,000,000
Other expenses-10,000,000-30,000,000-224,000,000-165,000,000
Operating expenses20,029,000,00020,857,000,00019,479,000,00022,629,000,000
Cost and expenses38,621,000,00042,127,000,00039,228,000,00042,500,000,000
Net interest income-1,430,000,000-1,512,000,000-1,306,000,000-1,409,000,000
Interest income292,000,000447,000,000429,000,000265,000,000
Interest expense1,722,000,0001,959,000,0001,735,000,0001,674,000,000
Depreciation and amortization4,055,000,0004,050,000,0003,933,000,0003,949,000,000
EBITDA2,648,000,0003,675,000,0004,047,000,00010,293,000,000
EBIT-1,407,000,000-375,000,000114,000,0006,344,000,000
Non-operating income (excl. interest)8,361,000,0004,854,000,0008,295,000,0001,895,000,000
Operating income6,954,000,0004,479,000,0008,409,000,0008,239,000,000
Total other income/expenses (net)-10,083,000,000-6,813,000,000-10,030,000,000-3,569,000,000
Income before tax-3,129,000,000-2,334,000,000-1,621,000,0004,670,000,000
Income tax expense466,000,000212,000,0001,321,000,000504,000,000
Net income from continuing operations-3,595,000,000-2,546,000,000-2,942,000,0004,166,000,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income-3,620,000,000-2,552,000,000-2,941,000,0004,150,000,000
Net income deductions0000
Bottom line net income-3,620,000,000-2,552,000,000-2,941,000,0004,150,000,000
EPS-4-3-34
Diluted EPS-4-3-34
Weighted average shares outstanding982,420,000982,420,000982,420,000982,420,000
Weighted average diluted shares outstanding982,420,000982,420,000982,420,000982,420,000

Bayer AG Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
30,785,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets110,606,000,000110,850,000,000116,259,000,000124,877,000,000
Total liabilities84,543,000,00078,805,000,00083,181,000,00085,951,000,000
Total equity25,947,000,00031,908,000,00032,927,000,00038,773,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents6,671,000,0006,191,000,0005,907,000,0005,171,000,000
Short-term investments1,185,000,0001,896,000,0004,680,000,0004,982,000,000
Cash and short-term investments7,856,000,0008,087,000,00010,587,000,00010,153,000,000
Net receivables12,190,000,0008,973,000,0009,348,000,00010,317,000,000
Accounts receivable8,896,000,0008,973,000,0009,343,000,00010,096,000,000
Other receivables3,294,000,000929,000,000628,000,0003,354,000,000
Inventory12,378,000,00013,467,000,00013,947,000,00013,595,000,000
Prepaid expenses0317,000,000123,000,0000
Other current assets23,000,0003,600,000,0003,674,000,0003,654,000,000
Total current assets32,447,000,00034,444,000,00037,556,000,00037,760,000,000
Property, plant and equipment (net)12,649,000,00013,456,000,00013,321,000,00013,674,000,000
Goodwill28,061,000,00030,016,000,00032,299,000,00039,648,000,000
Intangible assets20,622,000,00018,429,000,00023,363,000,00024,183,000,000
Goodwill and intangible assets48,683,000,00048,445,000,00055,662,000,00063,831,000,000
Long-term investments3,129,000,0003,022,000,0003,446,000,000-2,087,000,000
Tax assets11,810,000,0006,164,000,00012,556,000,0005,605,000,000
Other non-current assets1,888,000,00011,483,000,0001,269,000,0006,094,000,000
Total non-current assets78,159,000,00076,406,000,00086,254,000,00087,117,000,000
Other assets00-7,551,000,0000
Total assets110,606,000,000110,850,000,000116,259,000,000124,877,000,000
Total payables7,776,000,0007,518,000,0007,456,000,0007,545,000,000
Accounts payable7,081,000,0007,518,000,0007,456,000,0007,545,000,000
Other payables695,000,000000
Accrued expenses2,726,000,0003,521,000,0002,495,000,0001,236,000,000
Short-term debt5,630,000,0005,004,000,0006,536,000,0007,579,000,000
Capital lease obligations (current)0309,000,000294,000,000282,000,000
Tax payables01,094,000,000619,000,0001,586,000,000
Deferred revenue3,761,000,00002,126,000,0004,198,000,000
Other current liabilities12,692,000,00012,600,000,00010,550,000,00014,244,000,000
Total current liabilities32,585,000,00028,952,000,00029,457,000,00035,084,000,000
Long-term debt30,785,000,00034,559,000,00037,232,000,00032,833,000,000
Capital lease obligations (non-current)1,027,000,000939,000,000944,000,000952,000,000
Deferred revenue (non-current)209,000,000343,000,000467,000,000602,000,000
Deferred tax liabilities (non-current)6,834,000,000865,000,000790,000,000727,000,000
Other non-current liabilities13,103,000,00013,154,000,00015,548,000,00015,753,000,000
Total non-current liabilities51,958,000,00049,853,000,00053,724,000,00050,867,000,000
Other liabilities0000
Capital lease obligations1,027,000,0001,248,000,0001,238,000,0001,234,000,000
Total liabilities84,543,000,00078,805,000,00083,181,000,00085,951,000,000
Treasury stock0000
Preferred stock0000
Common stock2,515,000,0002,515,000,0002,515,000,0002,515,000,000
Retained earnings6,726,000,0009,867,000,00012,175,000,00017,233,000,000
Additional paid-in capital18,261,000,00018,261,000,00018,261,000,00018,261,000,000
Accumulated other comprehensive income/loss-1,555,000,00019,526,000,000-24,000,000764,000,000
Other stockholders' equity0000
Total stockholders' equity25,947,000,00031,908,000,00032,927,000,00038,773,000,000
Total equity26,063,000,00032,045,000,00033,078,000,00038,926,000,000
Minority interest116,000,000137,000,000151,000,000153,000,000
Total liabilities and total equity110,606,000,000110,850,000,000116,259,000,000124,877,000,000
Total investments4,314,000,0004,918,000,0008,131,000,0002,895,000,000
Total debt37,442,000,00040,811,000,00044,789,000,00041,646,000,000
Net debt30,771,000,00034,620,000,00038,882,000,00036,475,000,000

Bayer AG Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations4,571,000,0007,368,000,0005,117,000,0007,093,000,000
Cash from investing-1,609,000,000164,000,000-4,014,000,000-2,381,000,000
Cash from financing-2,186,000,000-7,178,000,000-679,000,000-4,220,000,000
Net change in cash480,000,000284,000,000736,000,000607,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income-3,620,000,000-2,546,000,000-2,941,000,0004,166,000,000
Depreciation and amortization4,055,000,0004,049,000,0003,933,000,0006,503,000,000
Deferred income tax-529,000,00000-2,067,000,000
Stock-based compensation058,000,000153,000,000365,000,000
Change in working capital6,151,000,000579,000,000-4,065,000,000-2,696,000,000
Accounts receivable-852,000,000197,000,000689,000,000269,000,000
Inventory475,000,000521,000,000-430,000,000-2,170,000,000
Accounts payable-176,000,000-120,000,00082,000,000612,000,000
Other working capital6,704,000,000-19,000,000-4,406,000,000-1,407,000,000
Other non-cash items-1,486,000,0005,228,000,0008,143,000,000822,000,000
Net cash from operating activities4,571,000,0007,368,000,0005,117,000,0007,093,000,000
Investments in property, plant and equipment-2,487,000,000-2,778,000,000-2,751,000,000-2,949,000,000
Acquisitions (net)217,000,000-167,000,000-493,000,0002,198,000,000
Purchases of investments-179,000,000-251,000,000-445,000,000-3,010,000,000
Sales/maturities of investments840,000,0002,576,000,000139,000,00032,000,000
Other investing activities0784,000,000-464,000,0001,348,000,000
Net cash from investing activities-1,609,000,000164,000,000-4,014,000,000-2,381,000,000
Net debt issuance-2,045,000,000-5,018,000,0003,253,000,000-974,000,000
Long-term net debt issuance-2,045,000,000-5,018,000,0003,253,000,000-974,000,000
Short-term net debt issuance0000
Net stock issuance-14,000,000-16,000,000-1,000,000-10,000,000
Net common stock issuance-14,000,000-16,000,000-1,000,00015,000,000
Common stock issuance0023,000,00015,000,000
Common stock repurchased-14,000,000-16,000,000-24,000,0000
Net preferred stock issuance000-25,000,000
Net dividends paid-127,000,000-131,000,000-2,379,000,000-1,965,000,000
Common dividends paid-127,000,000-131,000,000-2,358,000,000-1,965,000,000
Preferred dividends paid00-21,000,000-20,000,000
Other financing activities0-2,013,000,000-1,552,000,000-1,251,000,000
Net cash from financing activities-2,186,000,000-7,178,000,000-679,000,000-4,220,000,000
Effect of FX changes on cash-296,000,000-68,000,000-185,000,000112,000,000
Net change in cash480,000,000284,000,000736,000,000607,000,000
Cash at end of period6,671,000,0006,191,000,0005,907,000,0005,171,000,000
Cash at beginning of period6,191,000,0005,907,000,0005,171,000,0004,564,000,000
Operating cash flow4,571,000,0007,368,000,0005,117,000,0007,093,000,000
Capital expenditure-2,487,000,000-2,778,000,000-2,751,000,000-2,949,000,000
Free cash flow2,084,000,0004,590,000,0002,366,000,0004,144,000,000
Income taxes paid0000
Interest paid0000